Agios Pharmaceuticals, Inc. (AGIO) vs Sarepta Therapeutics, Inc. (SRPT)
Agios Pharmaceuticals, Inc. and Sarepta Therapeutics, Inc. are both Biotechnology companies. Agios Pharmaceuticals, Inc. and Sarepta Therapeutics, Inc. are of similar size ($2.0B and $2.0B). Agios Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 140.6% against −20.4%. Sarepta Therapeutics, Inc. has the higher net margin (−6.93% vs −418.2%) and the higher return on invested capital (−5.64% vs −70.2%). Across the 18 metrics below, Sarepta Therapeutics, Inc. leads on 13 and Agios Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | AGIO | SRPT | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.99% | 59.09% | 65.16% |
| Operating margin | (466.78%) | (7.26%) | 0.00% |
| Net margin | (418.24%) | (6.93%) | 0.00% |
| Free cash flow margin | (371.43%) | 3.80% | 0.00% |
| Return on equity | (34.34%) | (9.48%) | (57.72%) |
| Return on assets | (31.89%) | (3.98%) | (49.22%) |
| Return on invested capital | (70.24%) | (5.64%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack